Self‐powered active sensing based on triboelectric generators

G Khandelwal, R Dahiya - Advanced Materials, 2022 - Wiley Online Library
The demand for portable and wearable chemical or biosensors and their expeditious
development in recent years has created a scientific challenge in terms of their continuous …

Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil

J Shi, L Wei - Journal of cardiovascular pharmacology, 2013 - journals.lww.com
Rho kinase (ROCK) is a major downstream effector of the small GTPase RhoA. ROCK
family, consisting of ROCK1 and ROCK2, plays central roles in the organization of actin …

Rho kinase as a therapeutic target in cardiovascular disease

M Surma, L Wei, J Shi - Future cardiology, 2011 - Future Medicine
Rho kinase (ROCK) belongs to the AGC (PKA/PKG/PKC) family of serine/threonine kinases
and is a major downstream effector of the small GTPase RhoA. ROCK plays central roles in …

[HTML][HTML] Ginsenoside Rg1 ameliorates rat myocardial ischemia-reperfusion injury by modulating energy metabolism pathways

L Li, CS Pan, L Yan, YC Cui, YY Liu, HN Mu… - Frontiers in …, 2018 - frontiersin.org
As a major ingredient of Radix ginseng, ginsenoside Rg1 (Rg1) has been increasingly
recognized to benefit the heart condition, however, the rationale behind the role is not fully …

[HTML][HTML] Ginsenoside Rb1 protects against ischemia/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway

YC Cui, CS Pan, L Yan, L Li, BH Hu, X Chang, YY Liu… - Scientific reports, 2017 - nature.com
Cardiac ischemia and reperfusion (I/R) injury remains a challenge for clinicians.
Ginsenoside Rb1 (Rb1) has been reported to have the ability to attenuate I/R injury, but its …

ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury

K He, L Yan, CS Pan, YY Liu, YC Cui… - American Journal …, 2014 - journals.physiology.org
Cardiac ischemia-reperfusion (I/R) injury remains a challenge for clinicians, which initiates
with energy metabolism disorder. The present study was designed to investigate the …

Fish capsules: a system for high‐throughput screening of combinatorial drugs

M Tang, X Duan, A Yang, S He, Y Zhou, Y Liu… - Advanced …, 2022 - Wiley Online Library
Large‐scale screening of molecules heavily relies on phenotyping of small living organisms
during preclinical development. However, deep profiling candidate therapeutics on whole …

[HTML][HTML] Gualou Xiebai decoction, a traditional Chinese medicine, prevents cardiac reperfusion injury of hyperlipidemia rat via energy modulation

LL Yan, WY Zhang, XH Wei, L Yan, CS Pan… - Frontiers in …, 2018 - frontiersin.org
Background: Gualou Xiebai Decoction (GLXB) is a classic prescription of Chinese medicine
used for the treatment of cardiac problems. The present study was designed to explore the …

Biohybrid triboelectric nanogenerator for label-free pharmacological fingerprinting in cardiomyocytes

X Ji, P Fang, B Xu, K Xie, H Yue, X Luo, Z Wang… - Nano Letters, 2020 - ACS Publications
The development of new drugs requires high-throughput and cost-effective pharmacological
assessment in relevant biological models. Here, we introduce a novel pharmacological …

An update on the association of protein kinases with cardiovascular diseases

F Amin, A Ahmed, A Feroz, PSS Khaki… - Current …, 2019 - ingentaconnect.com
Background: Protein kinases are the enzymes involved in phosphorylation of different
proteins which leads to functional changes in those proteins. They belong to serine …